All News

Study examines the effect of a low-calorie, plant-based diet combined with vitamin C in helping to kill cancer cells.

Cancer care providers have increasingly been using biosimilars on a case-by-case basis with patients.

There is evidence that Robert Louis Stevenson wrote Dr. Jekyll and Mr. Hyde after being prescribed cocaine. What illness were they trying to treat?

Mesalamine suppositories are used to treat mild to moderate ulcerative colitis.

Gilead Sciences is increasing the global supply of the investigational drug remdesivir in preparation for demand in fighting COVID-19.

The Department of Health and Human Services awarded $101 million, mostly to rural communities, to fight the opioid epidemic.

Top news of the week from Pharmacy Times®.

Belantamab mafodotin-blmf is the first anti-BCMA therapy approved by the FDA for the treatment of patients with relapsed or refractory multiple myeloma who received at least 4 prior therapies.

New testing method may improve the speed, handling time, and cost of laboratory tests for coronavirus disease 2019.

Study suggests the ability of younger children to transmit COVID-19 may have been under-recognized because of the rapid, long-term closure of schools and daycares during the pandemic.

JD Power 2020 US Pharmacy Study ranks Good Neighbor Pharmacy highest among brick-and-mortar chain drug store pharmacies in customer satisfaction.

Researchers find a link between bacterial infections and the development of late diabetic complications and coronary heart disease.

A new study found that Medicare Part D prescription drug insurance plans largely favor generic drugs over brand-name counterparts, despite previous reports to the contrary.

Study finds that health care systems need to develop additional strategies to protect workers from COVID-19.

With a growing number of products containing cannabidiol and kratom available in the marketplace, many pharmacists and pharmacy students are increasingly being asked to discuss the use of these products.

Emergency department visits dropped significantly in March as the public responded to shelter-in-place messages as a result of the COVID-19 pandemic, according to a new study from researchers at Yale University and the Mayo Clinic.

Perhaps no other health care worker has been exposed to the opioid epidemic more frequently than pharmacy technicians and pharmacists.

Certain changes can be made to operations that minimize interruptions to pharmacy managers, reduce errors, and facilitate greater quality of work life.

Heart failure is the leading cause of hospitalization in the US, and the risk of death in people with heart failure rises with each hospital admission.

The FDA has approved a new generic equivalent to Levitra for erectile dysfunction.

In a recent statement, the FDA provided some guidelines for health care professionals when prescribing or renewing an opioid analgesic or medicine to treat opioid use disorder.

Some medications that may not function as intended when used with medical cannabinoids, CBD oil, and medical or recreational marijuana were compiled to further test the effects on prescription drugs.

A temporary public policy change and insurers' expanded benefits have allowed the growth of telehealth services during the COVID-19 pandemic.

Vizient report shows that the COVID-19 pandemic resulted in a $200 million increase in the top 10 COVID-related drugs, as well as a decrease in vaccinations between March and April.

With the groundbreaking advancements in specialty pharmacy, it is important to recognize the uniqueness of these medications and their respective patient populations.

Pharmacy Times spoke with Jessica Langley, MS, executive director of education and advocacy of NHA, about how the pandemic has changed the pharmacy technician industry and advice for future pharmacy technician opportunities.

Study shows an increase in anxiety and depression among college students since the start of the coronavirus disease 2019 pandemic.

Research may address the lack of effective treatments for mental fatigue among patients with multiple sclerosis.